TelyRx Holdings Inc.
TELYF
$1.78
-$0.10-5.32%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 22.67M | 19.39M | 14.31M | 12.34M | 9.34M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 22.67M | 19.39M | 14.31M | 12.34M | 9.34M |
| Cost of Revenue | 9.66M | 8.69M | 4.05M | 6.42M | 4.25M |
| Gross Profit | 13.02M | 10.71M | 10.27M | 5.92M | 5.09M |
| SG&A Expenses | 18.16M | 13.35M | 13.08M | 6.54M | 6.02M |
| Depreciation & Amortization | 307.00K | 252.00K | 397.00K | 156.00K | 171.00K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 28.12M | 22.28M | 17.11M | 13.29M | 10.44M |
| Operating Income | -5.45M | -2.89M | -2.80M | -948.00K | -1.10M |
| Income Before Tax | -4.47M | -4.68M | -3.08M | -1.06M | -1.23M |
| Income Tax Expenses | -- | -- | 18.00K | -- | -- |
| Earnings from Continuing Operations | -4.47M | -4.68M | -3.10M | -1.06M | -1.23M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -4.47M | -4.68M | -3.10M | -1.06M | -1.23M |
| EBIT | -5.45M | -2.89M | -2.80M | -948.00K | -1.10M |
| EBITDA | -5.41M | -2.85M | -2.77M | -925.70K | -929.00K |
| EPS Basic | -0.09 | -0.42 | -0.29 | -0.10 | -0.12 |
| Normalized Basic EPS | -0.07 | -0.13 | -0.18 | -0.06 | -0.07 |
| EPS Diluted | -0.09 | -0.42 | -0.29 | -0.10 | -0.12 |
| Normalized Diluted EPS | -0.07 | -0.13 | -0.18 | -0.06 | -0.07 |
| Average Basic Shares Outstanding | 48.86M | 11.27M | 10.69M | 10.69M | 10.69M |
| Average Diluted Shares Outstanding | 48.86M | 11.27M | 10.69M | 10.69M | 10.69M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |